+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Oral Proteins & Peptides Market Research Report by Drug Type (Calcitonin, Insulin, and Linaclotide), Application, State (Ohio, Texas, and California) - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 148 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5123828
UP TO OFF until Dec 31st 2022
The United States Oral Proteins & Peptides Market size was estimated at USD 223.16 million in 2021, USD 265.36 million in 2022, and is projected to grow at a CAGR 15.19% to reach USD 521.38 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Oral Proteins & Peptides to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Type, the market was studied across Calcitonin, Insulin, Linaclotide, Octreotide, and Plecanatide.
  • Based on Application, the market was studied across Bone Diseases, Diabetes, Gastric & Digestive Disorders, and Hormonal Disorders.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Oral Proteins & Peptides market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Oral Proteins & Peptides Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Oral Proteins & Peptides Market, including Allergan Plc., AstraZeneca PLC, Biocon Limited, Chiasma Inc., Generex Biotechnology Corp., Novo Nordisk A/S, Oramed Pharmaceuticals Inc., Proxima Concepts Limited, Synergy Pharmaceuticals Inc., and Tarsa Therapeutics Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Oral Proteins & Peptides Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Oral Proteins & Peptides Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Oral Proteins & Peptides Market?
4. What is the competitive strategic window for opportunities in the United States Oral Proteins & Peptides Market?
5. What are the technology trends and regulatory frameworks in the United States Oral Proteins & Peptides Market?
6. What is the market share of the leading vendors in the United States Oral Proteins & Peptides Market?
7. What modes and strategic moves are considered suitable for entering the United States Oral Proteins & Peptides Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Oral Proteins & Peptides Market, by Drug Type
6.1. Introduction
6.2. Calcitonin
6.3. Insulin
6.4. Linaclotide
6.5. Octreotide
6.6. Plecanatide
7. Oral Proteins & Peptides Market, by Application
7.1. Introduction
7.2. Bone Diseases
7.3. Diabetes
7.4. Gastric & Digestive Disorders
7.5. Hormonal Disorders
8. California Oral Proteins & Peptides Market9. Florida Oral Proteins & Peptides Market10. Illinois Oral Proteins & Peptides Market11. New York Oral Proteins & Peptides Market12. Ohio Oral Proteins & Peptides Market13. Pennsylvania Oral Proteins & Peptides Market14. Texas Oral Proteins & Peptides Market
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Allergan Plc.
16.2. AstraZeneca PLC
16.3. Biocon Limited
16.4. Chiasma Inc.
16.5. Generex Biotechnology Corp.
16.6. Novo Nordisk A/S
16.7. Oramed Pharmaceuticals Inc.
16.8. Proxima Concepts Limited
16.9. Synergy Pharmaceuticals Inc.
16.10. Tarsa Therapeutics Inc.
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET DYNAMICS
FIGURE 8. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2027
FIGURE 11. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LINACLOTIDE, 2019-2027 (USD MILLION)
FIGURE 16. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LINACLOTIDE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY OCTREOTIDE, 2019-2027 (USD MILLION)
FIGURE 18. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY OCTREOTIDE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PLECANATIDE, 2019-2027 (USD MILLION)
FIGURE 20. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PLECANATIDE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 22. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2027
FIGURE 24. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY BONE DISEASES, 2019-2027 (USD MILLION)
FIGURE 25. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY BONE DISEASES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES, 2019-2027 (USD MILLION)
FIGURE 27. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 28. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GASTRIC & DIGESTIVE DISORDERS, 2019-2027 (USD MILLION)
FIGURE 29. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GASTRIC & DIGESTIVE DISORDERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 30. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, 2019-2027 (USD MILLION)
FIGURE 31. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 32. CALIFORNIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. FLORIDA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. ILLINOIS ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. NEW YORK ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. OHIO ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. PENNSYLVANIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. TEXAS ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 40. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 41. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES ORAL PROTEINS & PEPTIDES MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LINACLOTIDE, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY OCTREOTIDE, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PLECANATIDE, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY BONE DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GASTRIC & DIGESTIVE DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. CALIFORNIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 17. CALIFORNIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 18. CALIFORNIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 19. FLORIDA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 20. FLORIDA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 21. FLORIDA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 22. ILLINOIS ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 23. ILLINOIS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 24. ILLINOIS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 25. NEW YORK ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 26. NEW YORK ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 27. NEW YORK ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 28. OHIO ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 29. OHIO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 30. OHIO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 31. PENNSYLVANIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 32. PENNSYLVANIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 33. PENNSYLVANIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 34. TEXAS ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 35. TEXAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 36. TEXAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 38. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 39. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 40. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET RANKING
TABLE 41. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SHARE, BY KEY PLAYER, 2021
TABLE 42. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET MERGER & ACQUISITION
TABLE 43. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 44. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 45. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET INVESTMENT & FUNDING
TABLE 46. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 47. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET: LICENSE & PRICING

Companies Mentioned

  • Allergan Plc.
  • AstraZeneca PLC
  • Biocon Limited
  • Chiasma Inc.
  • Generex Biotechnology Corp.
  • Novo Nordisk A/S
  • Oramed Pharmaceuticals Inc.
  • Proxima Concepts Limited
  • Synergy Pharmaceuticals Inc.
  • Tarsa Therapeutics Inc.

Methodology

Loading
LOADING...